Newland Pharmaceutical's Amlodipine Besylate API has received NMPA marketing approval, marking another step forward in the company's cardiovascular API portfolio.

On July 18, Xintiandi Pharma held the Phase I commendation and training activity for the Amoeba Management Project in the multi-functional lecture hall on the third floor of the company. The event was attended by the company’s middle and senior management personnel, all Amoeba leaders, and senior consultants from Bomington Consulting. Centering on phased work summary, outstanding employee recognit

Join us at Booth L49 to explore new opportunities in the ASEAN pharmaceutical market and discuss potential partnerships.

Newland Pharmaceutical's Levamlodipine Besylate API is now approved for marketing by the NMPA.

Newland Pharmaceutical connects with global industry partners at CPHI China 2026, highlighting its APIs, intermediates, and CDMO capabilities.